MedPath

Yonsei University

Yonsei University logo
🇰🇷South Korea
Ownership
Private
Established
1885-01-01
Employees
5K
Market Cap
-
Website
http://www.yonsei.ac.kr

The Chemopreventive Effect of Metformin in Patients With Familial Adenomatous Polyposis: Double Blinded Randomized Controlled Study

Phase 2
Completed
Conditions
Familial Adenomatous Polyposis
Interventions
Drug: Placebo
First Posted Date
2012-11-12
Last Posted Date
2021-09-20
Lead Sponsor
Yonsei University
Target Recruit Count
34
Registration Number
NCT01725490
Locations
🇰🇷

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea, Republic of

Intramuscular Diclofenac in the Prevention of Post-ERCP Pancreatitis

Not Applicable
Completed
Conditions
Post ERCP Pancreatitis
Interventions
Drug: normal saline
First Posted Date
2012-10-30
Last Posted Date
2021-05-04
Lead Sponsor
Yonsei University
Target Recruit Count
343
Registration Number
NCT01717599
Locations
🇰🇷

Division of Gastroenterology, Department of Internal Medicine, Yonsei Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea, Republic of

Prospective Cohort Study for Analyzing the Effect of Gastric Cancer Surgery to the Metabolic Syndrome and Insulin Resistance

Withdrawn
Conditions
Gastric Cancer With Metabolic Syndrome or Metabolic Disease
Interventions
Procedure: subtotal gastrectomy with gastroduodenostomy
Procedure: subtotal gastrectomy with Roux-en-Y gastrojejunostomy,
Procedure: total gastrectomy with Rou-en-Y esophagojejunostomy
First Posted Date
2012-10-26
Last Posted Date
2019-03-29
Lead Sponsor
Yonsei University
Registration Number
NCT01714622
Locations
🇰🇷

Department of Surgery, Yonsei University Colleage of Medicine,, Seoul, Korea, Republic of

🇰🇷

Ji Yeong An, Seoul, Korea, Republic of

🇰🇷

Sevrance hospital, Department of General surgery, Seoul, Korea, Republic of

The Correlation Between Renal Injury and Biomarkers in Pediatric Ureteropelvic Junction Obstruction Patients

Withdrawn
Conditions
Ureteropelvic Junction Obstruction
First Posted Date
2012-10-23
Last Posted Date
2021-05-06
Lead Sponsor
Yonsei University
Registration Number
NCT01711996
Locations
🇰🇷

Department of Urology, Urological Science Institute, Yonsei University, Colleage of Medicine, Seoul, Korea, Republic of

Safety and Efficacy of the Early Introduction of Everolimus (Certican®) With Low Dose of Cyclosporine in de Novo Kidney Recipients After 1 Month of Transplantation

Phase 4
Completed
Conditions
Planned Kidney Transplantation
Interventions
Drug: Myfortic+ Standard CsA + PD
First Posted Date
2012-10-15
Last Posted Date
2014-02-19
Lead Sponsor
Yonsei University
Target Recruit Count
60
Registration Number
NCT01706471
Locations
🇰🇷

Department of Surgery, Yonsei University College of Medicine, Severance Hospital, Seoul, Korea, Republic of

A Comparison of the Perception of a Needle Injection Pain Between Cancer Patients Receiving Opioid Therapy Versus Opioid-naive Patients

Not Applicable
Completed
Conditions
Cancer Patients
Interventions
Procedure: The local anesthetic injection
First Posted Date
2012-10-11
Last Posted Date
2012-10-11
Lead Sponsor
Yonsei University
Target Recruit Count
80
Registration Number
NCT01704469
Locations
🇰🇷

Severance hospital, Seoul, Korea, Republic of

Prospective Randomized Trial Comparing the Effectiveness of Continuous Paravertebral Infusion of Local Anesthetics Versus Intravenous Patient-controlled Analgesia on Acute and Chronic Neuropathic Pain After VATS Lobectomy

Phase 2
Completed
Conditions
Lung Neoplasms
Postoperative Pain
Interventions
First Posted Date
2012-10-10
Last Posted Date
2019-01-31
Lead Sponsor
Yonsei University
Target Recruit Count
79
Registration Number
NCT01703351
Locations
🇰🇷

Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine, Seoul, Korea, Republic of

Changes of Keratometric Value and Ocular Aberration After Treatment of Meibomian Gland Dysfunction

Withdrawn
Conditions
Moderate and Severe Meibomiang Gland Dysfunction (Stage 3 or Stage 4 Meibomiang Gland Dysfunction)
First Posted Date
2012-09-25
Last Posted Date
2014-02-19
Lead Sponsor
Yonsei University
Registration Number
NCT01692665

Changes of Inflammatory Cytokines in the Tears of Moderate and Severe MGD Treated With Topical Loteprednol Etabonate

Not Applicable
Completed
Conditions
Moderate and Severe Meibomiang Gland Dysfunction (Stage 3 or Stage 4 Meibomiang Gland Dysfunction)
Interventions
Drug: topical loteprednol etabonate (lotemax 0.5%) with warm compress & ocular massage
Other: warm compress only group
First Posted Date
2012-09-25
Last Posted Date
2014-02-19
Lead Sponsor
Yonsei University
Target Recruit Count
98
Registration Number
NCT01692652
Locations
🇰🇷

department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea, Republic of

Effect of Dexmedetomidine on Sevoflurane Requirements and Emergence Agitation in Children Undergoing Ambulatory Surgery

Not Applicable
Completed
Conditions
Ambulation Difficulty
Interventions
Drug: normal saline
First Posted Date
2012-09-24
Last Posted Date
2012-09-24
Lead Sponsor
Yonsei University
Target Recruit Count
40
Registration Number
NCT01691001
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath